InvestorsHub Logo
Followers 62
Posts 7484
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Monday, 10/20/2014 7:42:00 AM

Monday, October 20, 2014 7:42:00 AM

Post# of 423519
Amarin must now have data, in their possession, indicating what percentage of new Rx's are being originated by Amarin's 125 reps and what percentage are coming from Kowa's 250 reps. This would give some indication of how the relationship with Kowa is going and, if necessary, what can be done to make it work even better. Some discussion of this issue at the C.C. would be helpful. Having been visited by reps, myself, I understand that personal relationships are helpful in getting the Doc's attention and willingness to assess the product. The Kowa reps have been in the field for almost 6 months now and I am hoping to see their of their efforts bearing fruit soon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News